Is Autonomix Medical, Inc. Common Stock (AMIX) overvalued? · $3.9M cap
Autonomix Medical, Inc. Common Stock (AMIX) is a medical devices company listed on US.
This page asks whether Autonomix Medical, Inc. Common Stock (AMIX) looks expensive on cached numbers — not a short thesis.
Latest reported AMIX revenue for 2025-03-31 was $0. Net income was -$11.4M. AMIX currently screens at market cap $3.9M.
AMIX currently screens at market cap $3.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AMIX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AMIX stock page for the full model, not this heading.
Not investment advice.